IGC Earnings IGC Pharma, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.02 | 2026-05-15 | 10-Q |
| Q2 2026 | 2025-09-30 | -0.04 | 2025-11-14 | 10-Q |
| Q1 2026 | 2025-06-30 | -0.02 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.02 | 2026-05-15 | 10-Q |
| Q3 2025 | 2024-12-31 | -0.08 | 2025-02-14 | 10-Q |
| Q2 2026 | 2024-09-30 | -0.06 | 2025-11-14 | 10-Q |
| Q1 2026 | 2024-06-30 | -0.03 | 2025-08-14 | 10-Q |
| FY 2025 | 2024-03-31 | -0.22 | 2025-06-27 | 10-K |
| Q3 2025 | 2023-12-31 | -0.18 | 2025-02-14 | 10-Q |
| Q2 2025 | 2023-09-30 | -0.08 | 2024-11-12 | 10-Q |
| Q3 2018 | 2017-12-31 | -0.04 | 2018-02-20 | 10-Q |
| Q2 2018 | 2017-09-30 | -0.02 | 2017-11-17 | 10-Q |
| Q1 2018 | 2017-06-30 | -0.02 | 2017-08-18 | 10-Q |
| FY 2017 | 2017-03-31 | -0.07 | 2017-07-14 | 10-K |
| Q3 2018 | 2016-12-31 | -0.04 | 2018-02-20 | 10-Q |
| Q2 2018 | 2016-09-30 | -0.04 | 2017-11-17 | 10-Q |
| Q1 2018 | 2016-06-30 | -0.02 | 2017-08-18 | 10-Q |
| FY 2017 | 2016-03-31 | -0.17 | 2017-07-14 | 10-K |
| Q3 2017 | 2015-12-31 | -0.09 | 2017-02-21 | 10-Q |
| Q2 2017 | 2015-09-30 | -0.07 | 2016-11-21 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.